CO2023018191A2 - Métodos de purificación de columnas de vectores de aav - Google Patents

Métodos de purificación de columnas de vectores de aav

Info

Publication number
CO2023018191A2
CO2023018191A2 CONC2023/0018191A CO2023018191A CO2023018191A2 CO 2023018191 A2 CO2023018191 A2 CO 2023018191A2 CO 2023018191 A CO2023018191 A CO 2023018191A CO 2023018191 A2 CO2023018191 A2 CO 2023018191A2
Authority
CO
Colombia
Prior art keywords
purification methods
aav vector
column purification
vector column
particles
Prior art date
Application number
CONC2023/0018191A
Other languages
English (en)
Spanish (es)
Inventor
Ohnmar Khanal
Vijesh Kumar
Mi Jin
Original Assignee
Spark Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spark Therapeutics Inc filed Critical Spark Therapeutics Inc
Publication of CO2023018191A2 publication Critical patent/CO2023018191A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361Ion-exchange
    • B01D15/363Anion-exchange
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/42Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/422Displacement mode
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
CONC2023/0018191A 2021-06-11 2023-12-21 Métodos de purificación de columnas de vectores de aav CO2023018191A2 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163209680P 2021-06-11 2021-06-11
US202263366094P 2022-06-09 2022-06-09
PCT/US2022/072859 WO2022261663A1 (en) 2021-06-11 2022-06-10 Aav vector column purification methods

Publications (1)

Publication Number Publication Date
CO2023018191A2 true CO2023018191A2 (es) 2024-01-25

Family

ID=84426294

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2023/0018191A CO2023018191A2 (es) 2021-06-11 2023-12-21 Métodos de purificación de columnas de vectores de aav

Country Status (13)

Country Link
US (1) US20240271159A1 (enExample)
EP (1) EP4351755A4 (enExample)
JP (1) JP2024525142A (enExample)
KR (1) KR20240021231A (enExample)
AU (1) AU2022289035A1 (enExample)
BR (1) BR112023025999A2 (enExample)
CA (1) CA3221540A1 (enExample)
CL (1) CL2023003646A1 (enExample)
CO (1) CO2023018191A2 (enExample)
IL (1) IL309070A (enExample)
MX (1) MX2023014809A (enExample)
PE (1) PE20240359A1 (enExample)
WO (1) WO2022261663A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025528182A (ja) * 2022-08-12 2025-08-26 ウルトラジェニックス ファーマシューティカル インコーポレイテッド 完全な組換えアデノ関連性ウイルス粒子から空の粒子を分離するための新規な陰イオン交換クロマトグラフィーの方法
EP4670812A1 (en) * 2024-06-27 2025-12-31 Sartorius Stedim Biotech GmbH CONTINUOUS POLISHING OF VIRAL CAPSIDES
WO2026064763A1 (en) * 2024-09-23 2026-03-26 Regeneron Pharmaceuticals, Inc. Partitioning anion exchange chromatography for purification of recombinant adeno-associated virus (raav)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7261544B2 (en) * 2003-05-21 2007-08-28 Genzyme Corporation Methods for producing preparations of recombinant AAV virions substantially free of empty capsids
US20120093775A1 (en) * 2009-03-27 2012-04-19 Proyecto De Biomedicina Cima, S.L. Methods and compositions for the treatment of cirrhosis and liver fibrosis
PE20200737A1 (es) * 2017-06-30 2020-07-23 Spark Therapeutics Inc Metodos de purificacion de columna de vector aav
WO2023077086A1 (en) * 2021-10-29 2023-05-04 Homology Medicines, Inc. Methods and compositions for the purification of adeno-associated virus
CN120283059A (zh) * 2022-10-11 2025-07-08 梅里特斯英国第二有限公司 纯化aav衣壳的色谱方法

Also Published As

Publication number Publication date
AU2022289035A1 (en) 2024-01-04
EP4351755A1 (en) 2024-04-17
CA3221540A1 (en) 2022-12-15
EP4351755A4 (en) 2025-04-23
JP2024525142A (ja) 2024-07-10
KR20240021231A (ko) 2024-02-16
US20240271159A1 (en) 2024-08-15
BR112023025999A2 (pt) 2024-02-27
IL309070A (en) 2024-02-01
PE20240359A1 (es) 2024-02-27
WO2022261663A1 (en) 2022-12-15
CL2023003646A1 (es) 2024-10-25
MX2023014809A (es) 2024-01-29

Similar Documents

Publication Publication Date Title
CO2023018191A2 (es) Métodos de purificación de columnas de vectores de aav
BR112012020254A2 (pt) método para a purificação de anticorpos a partir de uma mistura de proteína e, unidade operacional única.
NO20076157L (no) Anti-TRKB monoklonale antistoffer og anvendelser derav
MX2024007103A (es) Metodos de purificacion por columna de vectores aav.
EP3712520B8 (en) Air purifier, air purifying system
BR112022021884A2 (pt) Proteínas que se ligam a nkg2d, cd16 e clec12a
MX2012011926A (es) Anticuerpos para el tratamiento de infeccion y enfermedad asociadas con clostridium dificile.
BR112012017124B8 (pt) método para produzir e para purificar um multímero polipeptídico
BR112016016916A8 (pt) uso de um anticorpo que se liga à calicreína plasmática ativa para tratamento de angiodema hereditário (hae)
WO2013078170A8 (en) Purification of anti-c-met antibodies
BR112014032567A2 (pt) purificação de iduronato-2-sulfatase
BR112014026058A2 (pt) composições para tratamento tópico de infecções microbianas
WO2008108830A3 (en) Immunogenic and therapeutic compositions for streptococcus pyogenes
BR112022023908A2 (pt) Composições de vírus adenoassociados para restauração da função do gene pah e métodos de uso das mesmas
EA201990593A1 (ru) Непрерывный способ для снижения гетерогенности терапевтического белка
MX2013012627A (es) Metodos para purificar virus utilizando cromatografia de permeacion en gel.
FR2881746B1 (fr) Epitopes t cd4+des antigenes de latence de type i et ii du virus epstein-barr aptes a etre reconnus par la majorite des individus de la population caucasienne et leurs applications
CL2021000176A1 (es) Uso de especies gram negativas para tratar la dermatitis atópica
WO2022170008A3 (en) Anti-il1rap antibodies
BR112018074966A2 (pt) anticorpos antagonísticos anti-molécula de orientação repulsiva a (grma) para tratar lesão na medula espinhal e dor
WO2012066569A8 (en) A novel process for the purification of tissue plasminogen activator
BR0207447A (pt) Polipeptìdeos e fragmentos de dna correspondentes de streptococcus pyogenes úteis como componentes de vacina
CY1117906T1 (el) Μεθοδος καθαρισμου για υδατανθρακα απο στρεπτοκοκκο ομαδας α
BR0116704A (pt) Antìgenos de streptococcus pyogenes e fragmentos de dna correspondentes
GB0423196D0 (en) Method